The global micro balloon catheter market is expected to be valued at $416 million by 2032, up from $286 million in 2022, with a CAGR of 3.4% over the forecast period.
The micro balloon catheter is a novel medical device that consists of a guidewire and a catheter. To treat constricted blood vessels, it is inserted into the femoral artery in the leg or, in some cases, the radial artery in the arm.
Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5860
The demand for micro balloon catheters is increasing due to the increasing prevalence of cardiovascular diseases. The micro balloon catheters also include minimally-invasive procedures for opening blocked or narrowed coronary arteries caused by coronary artery diseases (CAD), which is bolstering the sales of the micro balloon catheters.
The micro balloons catheter market is likely to witness significant growth during the forecast period as there is a rise in the prevention of heart attack and angina in patients suffering from coronary artery diseases.
What are the Key Driving and Restraining Factors in the Micro Balloon Catheters Market?
The major factors driving the growth of the micro balloon catheter market are the rising prevalence of cardiac diseases and the increasing geriatric population. There are growing cases of cardiology intervention procedures worldwide, which is fueling the demand for micro balloon catheters.
Moreover, the surge of interventional cardiology has been facilitating the utilization of micro balloon catheters, and there is a rise in the prevalence of patients affected with end-age renal diseases that are bolstering the sales of micro balloon catheters.
Furthermore, the number of patients seeking renal replacement therapy has also increased. Leading manufacturers of catheter devices are developing efficient and cost-effective solutions. These incidences are anticipated to influence the growth of the micro balloon catheter market over the coming years.
Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-5860
What is the Regional Outlook for the Micro Balloon Catheters Market?
North America is estimated to account for the largest share of micro balloon catheters market share, comprising 33% of the global market share for micro balloon catheters.
However, in terms of revenue, Europe will account for the largest share of the market during the forecast period.
The factors driving the growth of the micro balloon market in these regions are an increase in patient awareness, simple access to innovative healthcare services, and growing demand for advanced micro balloon catheters are accelerating the market growth in these regions.
The increasing number of patients undergoing cardiac surgeries has increased the demand for micro balloon catheters. Micro balloon catheters are segmented on the basis of material, indication, and end-user. On the basis of material, a micro balloon catheter is classified as latex, silicone, and others. Therefore, these regions are expected to boom in the forecast period.
Who are the key players in the Micro Balloon Catheters Market?
The key players in the micro balloon catheters market are: Terumo Corporation, Cook Medical, Piolax Medical Devices Inc., Boston Scientific Corporation, Stryker Corporation, Medtronic plc., Edward Life Sciences Corporation, MicroPort Scientific Corporation, B. Braun Melsungen AG.
What are the Key Trends and Notable Developments in the Micro Balloon Catheters Market?
Some of the notable developments in the micro balloon catheter market are:
- In July 2021, Medtronic launched the newest-generation drug-coated balloon catheter ‘Prevail’ for the treatment of coronary artery disease in Europe after the device was awarded the CE (Conformité Européene) mark.
- In June 2021, Neurescue received the 510k clearance from the US Food and Drug Administration for their NEURESCUE® device, ‘the world’s first intelligent balloon catheter’, devised for the temporary occlusion of large vessels such as the aorta.
- In March 2021, Alvimedica received the CE mark approval for their Fluydo NC, a new PTCA NON-COMPLIANT Balloon Catheter. The device comprises a new Non-Compliant Balloon designed to dilate the hardest lesions located into the most difficult and challenging coronary lesions in an efficient manner.
Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-5860
Key Segments
By Indication:
- Coronary Artery Diseases
- Peripheral Vascular Disease
By End-Users:
- Public Hospitals & Private Hospitals
- Ambulatory Surgical Centres
- Cardiac Catheterisation Laboratories
By Balloon Type:
- High-Pressure Balloons
- Elastomeric Balloons
By Catheter Type:
- Over-The-Wire (OTW) Balloon Catheters
- Rapid Exchange (RX) Balloon Catheters
- Fixed-Wire (FW) Balloon Catheters
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: [email protected]
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs